ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CADL Candel Therapeutics Inc

5.91
0.00 (0.00%)
Pre Market
Last Updated: 06:04:59
Delayed by 15 minutes

Candel Therapeutics Financial Summary

The current CADL market cap is 170.92M. The company's latest EPS is USD -1.3119 and P/E is -4.50.

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)
Total Revenue 31k31k000
Operating Income -8.88M-8.1M-9.63M-9.58M-8.86M
Net Income -8.69M-5.08M-8.8M-9.61M-8.44M
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Total Revenue 125k125k0
Operating Income -25.73M-34.72M-38.39M
Net Income -36.12M-18.79M-37.94M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)
Total Assets 85.01M77.69M67.24M58.71M50.06M
Total Liabilities 32.88M29.98M27.59M27.94M27.04M
Total Equity 52.13M47.71M39.65M30.77M23.02M
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Total Assets 89.21M77.69M41.2M
Total Liabilities 25.07M29.98M28.46M
Total Equity 64.14M47.71M12.75M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)
Operating -24.53M-31.42M-10.82M-18.01M-26.82M
Investing -1.02M-1.3M19k-150k-253k
Financing 19.94M19.97M N/A N/A N/A
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Operating -22.22M-31.42M-34.24M
Investing -1.84M-1.3M-280k
Financing 71.8M19.97M-121k
Market Cap 170.92M
Price to Earnings Ratio -4.50
Price to Sales Ratio 0
Price to Cash Ratio 4.83
Price to Book Ratio 13.41
Dividend Yield -

Share Statistics

Shares Outstanding 28.92M
Average Volume (1 week) 628.85k
Average Volume (1 Month) 17.16M
52 Week Change 322.14%
52 Week High 11.3999
52 Week Low 0.66
Spread (Intraday) 0.07 (1.15%)

Company Info

Company Name Candel Therapeutics Inc
Address 1209 orange street
wilmington, delaware 19801
Website https://www.candeltx.com
Industry biological pds,ex diagnstics (2836)

Your Recent History

Delayed Upgrade Clock